BridgeMD
New treatment option for Flexible Flatfoot or Pes Planus
Official title Effect of a Semirigid Foot Insole in Flexible Pes Planus
ClinicalTrials.gov ID: NCT07389343
What this study is testing
- What it's testing
- The goal of this clinical trial is to investigate the effect of a semirigid foot insole on radiological angle correction in people with asymptomatic flexible flat feet. The X-ray will be performed while standing barefoot one time and the other while standing on the insole from 2 views.
- Time commitment: about 3 months
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 35
You may be able to join if
- Asymptomatic people with flexible pes planus. If the pain is greater than 3 out of 10 on the visual analog scale in the last 3 months, the patient is...
- Aged 18-35.
- BMI max 29.9 kg/cm².
You likely can't join if
- Osteoarthritis of the joints of the foot (excluded by x-ray).
- Foot Deformities (e.g. Hallux Valgus)
- Old fractures of the foot.
- Previous injuries to the ankle.
- Previous surgeries to the lower limb. 6. Calcaneal Spur. 7. Foot and ankle ligaments tear. 8- Systemic diseases such as rheumatoid arthritis. (Gouty...
The study team makes the final eligibility decision.
Where it's taking place
- Giza, Egypt
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 3 months per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 35 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Giza, Egypt. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.